D. E. Shaw & Co., Inc. - ALDER BIOPHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of ALDER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$1,300,000
+100.9%
68,923
+25.5%
0.00%
+100.0%
Q2 2019$647,000
-38.1%
54,912
-46.2%
0.00%0.0%
Q4 2018$1,045,000
+301.9%
101,993
+553.7%
0.00%
Q3 2018$260,000
+17.6%
15,603
-13.5%
0.00%
Q3 2017$221,000
-62.7%
18,038
-0.4%
0.00%
-100.0%
Q3 2016$593,000
-68.6%
18,109
-76.5%
0.00%
-66.7%
Q1 2016$1,887,000
+331.8%
77,044
+482.7%
0.00%
+200.0%
Q4 2015$437,000
-5.6%
13,223
-6.4%
0.00%0.0%
Q3 2015$463,000
-76.8%
14,130
-62.5%
0.00%
-66.7%
Q2 2015$1,998,000
-3.1%
37,724
-47.2%
0.00%0.0%
Q1 2015$2,062,000
+623.5%
71,458
+628.4%
0.00%
Q4 2014$285,0009,8100.00%
Other shareholders
ALDER BIOPHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 1,628,328$33,869,00014.72%
Foresite Capital Management II, LLC 995,396$20,704,00010.39%
Cormorant Asset Management, LP 1,581,604$32,897,0004.43%
DAFNA Capital Management LLC 221,013$4,597,0004.04%
New Leaf Venture Partners, L.L.C. 228,428$4,751,0003.40%
Partner Investment Management, L.P. 63,571$1,322,0001.75%
Iguana Healthcare Management, LLC 140,000$2,912,0001.74%
PFM Health Sciences, LP 2,913,951$60,610,0001.71%
Redmile Group, LLC 920,550$19,147,0001.65%
SECTORAL ASSET MANAGEMENT INC 669,351$13,923,0001.54%
View complete list of ALDER BIOPHARMACEUTICALS INC shareholders